Non-Malignant Recurrent Effusions

Pleural Catheters Market to Witness Huge R&D Investment in the Coming Years

Kategorie der Pressemeldung: 
Mitteilung: 

An increase in the demand for pleural catheters from surgeons, pulmonologists and physicians on the back of pleural catheters’ ability to provide effective fluid control with minimal risk. Projecting the market growth at a healthy CAGR of 6.4%, a new market study of Fact.MR provides an inclusive analysis of the pleural catheters market. This growth is further complemented by the increasing adoption of pleural catheters coupled with reduced hospitalization.

Pleural Catheters Market – Key Takeaways

Malignant pleural effusion will remain the top indication type, with three-quarters of revenue share, owing to frequent utilization of clinical management of both malignant and benign effusion.
Owing to the availability of pleural catheters and skilled personnel for better clinical management of patients, hospitals account for 2/3rd of overall market value.
Developed regional markets collectively account for more than 60%, on the back of rising elderly population and increase in accessibility to healthcare facilities.
An increase in the prevalence of COPD and the expansion of private hospitals in rural areas are boosting the demand for pleural catheters in Asia Pacific.
Request for Sample detailed COVID-19 impact analysis on the Market @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3128